Effects of irradiation on the [methyl-3H]choline uptake in the human prostate cancer cell lines LNCaP and PC3

Strahlentherapie und Onkologie

Volumn 184, Issue 6, 2008, Pages 319-324

  Holzapfel, Korbinian ^a   Müller, Sebastian A ^a   Seidl, Christof ^a   Grosu, Anca Ligia ^a   Schwaiger, Markus ^a   Senekowitsch Schmidtke, Reingard ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Choline PET; Choline uptake; Irradiation; Prostate cancer cell lines

Indexed keywords

ANDROGEN; CHOLINE DERIVATIVE; TRACER;

ARTICLE; CANCER CELL CULTURE; CANCER RADIOTHERAPY; CELL DEATH; CELL LINE; CELL SURVIVAL; CLONOGENIC ASSAY; DOSE RESPONSE; DRUG UPTAKE; HUMAN; HUMAN CELL; MICHAELIS CONSTANT; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; RADIATION DOSE;

CELL LINE, TUMOR; CELL SURVIVAL; CHOLINE; DOSE-RESPONSE RELATIONSHIP, RADIATION; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; TRITIUM; TUMOR CELLS, CULTURED; TUMOR STEM CELL ASSAY;

EID: 44949225414     PISSN: 01797158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00066-008-1799-1     Document Type: Article

References (44)

1. Algan O, Stobbe CC, Helt AM, et al. Radiation inactivation of human prostate cancer cells: the role of apoptosis. Radiat Res 1996;146:267-75.
2. Avril N, Schelling M, Dose J, et al. Utility of PET in breast cancer. Clin Positron Imaging 1999;2:261-71.
3. 11C]choline does not correlate with cell proliferation in human prostate cancer. Eur J Nucl Med Mol Imaging 2005;32:668-73.
4. Breul J, Zimmermann F, Dettmar P, et al. Prostatakarzinom. In: Liedl B, Tumorzentrum München, Hrsg. Manual Urogenitale Tumoren. Empfehlungen zur Diagnostik, Therapie und Nachsorge, 3. Aufl. München: Zuckschwerdt, 2003:1-42.
5. Brun E, Kjellen E, Tennvall J, et al. FDG PET studies during treatment: prediction of therapy outcome in head and neck squamous cell carcinoma. Head Neck 2002;24:127-35.
6. Burckhardt G, Wolff NA. Structure of renal organic anion and cation transporters. Am J Physiol Renal Physiol 2000;278:F853-66.
7. (18)F-labeled choline analogs as oncologic PET tracers. J Nucl Med 2001;42:1805-14.
8. 11C-choline PET. J Nucl Med 2003;44:331-5.
9. 11C-choline positron emission tomography for the evaluation after treatment of localized prostate cancer. Eur Urol 2003;44:32-8.
10. Gillies NE. Radiation damage to cell membranes: insights from the oxygen effect. Int J Radiat Biol 1997;71:643-8.
11. Goldner G, Wachter S, Wachter-Gerstner N, et al. Long-term results in three-dimensional conformal radiotherapy of localized prostate cancer at moderate dose (66 Gy). Strahlenther Onkol 2006;182:537-42.
12. Grosu AL, Piert M, Molls M. Experience of PET for target localisation in radiation oncology. Br J Radiol 2005;Suppl 28:18-32.
13. Grosu AL, Piert M, Weber WA, et al. Positron emission tomography for radiation treatment planning. Strahlenther Onkol 2005;181:483-99.
14. Haberkorn U, Morr I, Oberdorfer F, et al. Fluorodeoxyglucose uptake in vitro: aspects of method and effects of treatment with gemcitabine. J Nucl Med 1994;35:1842-50.
15. Hara T, Kosaka N, Kishi H. PET imaging of prostate cancer using carbon-11-choline. J Nucl Med 1998;39:990-5.
16. 18F]dOC). Nucl Med Biol 2004;31:851-8.
17. Higashi K, Clavo AC, Wahl RL. In vitro assessment of 2-fluoro-2-deoxy-D- glucose, L-methionine and thymidine as agents to monitor the early response of a human adenocarcinoma cell line to radiotherapy. J Nucl Med 1993;34:773-9.
18. Hille A, Töws N, Schmidberger H, et al. A prospective three-dimensional analysis about the impact of differences in the clinical target volume in prostate cancer irradiation on normal-tissue exposure. Strahlenther Onkol 2005;181:789-95.
19. Hofer C, Laubenbacher C, Block T, et al. Fluorine-18-fluoro-deoxyglucose positron emission tomography is useless for the detection of local recurrence after radical prostatectomy. Eur Urol 1999;36:31-5.
20. Jereczek-Fossa BA, Cattani F, Garibaldi C, et al. Transabdominal ultrasonography, computed tomography and electronic portal imaging for 3-dimensional conformal radiotherapy for prostate cancer. Strahlenther Onkol 2007;183:610-6.
21. Kimura K, Gelmann EP. Propapoptotic effects of NF-kappaB in LNCaP prostate cancer cells lead to serine protease activation. Cell Death Differ 2002;9:972-80.
22. Kotzerke J, Prang J, Neumaier B, et al. Experience with carbon-11 choline positron emission tomography in prostate carcinoma. Eur J Nucl Med 2000;27:1415-9.
23. 3) spatial resolution. Radiology 1996;198:795-805.
24. Larson SM, Erdi Y, Akhurst T, et al. Tumor treatment response based on visual and quantitative changes in global tumor glycolysis using PET-FDG imaging: the Visual Response Score and the change in total lesion glycolysis. Clin Positron Imaging 1999;2:159-71.
25. Li WX, Franklin WA. Radiation- and heat-induced apoptosis in PC-3 prostate cancer cells. Radiat Res 1998;150:190-4.
26. Lu S, Epners DE. Molecular mechanisms of cell cycle block by methionine restriction in human prostate cancer cells. Nutr Cancer 2000;38:123-30.
27. Martin T, Baltas D, Kurek R, et al. 3-D conformal HDR brachytherapy as monotherapy for localized prostate cancer. Strahlenther Onkol 2004;180:225-32.
28. Meller B, Deisting W, Wenzel BE, et al. Increased radioiodine uptake of thyroid cell cultures after external irradiation. Strahlenther Onkol 2006;182:30-6.
29. Okuda T, Haga T, Kanai Y, et al. Identification and characterization of the high-affinity choline transporter. Nat Neurosci 2000;3:120-5.
30. O'Regan S, Meunier FM. Selection and characterization of the choline transport mutation suppressor from Torpedo electric lobe, CTL1. Neurochem Res 2003;28:551-5.
31. Pearce A, Choo R, Danjoux C, et al. Effect of combined treatment with salvage radiotherapy plus androgen suppression on quality of life in patients with recurrent prostate cancer after radical prostatectomy. Int J Radiat Oncol Biol Phys 2006;65:78-83.
32. 18F]fluorodeoxyglucose-positron emission tomography. J Urol 2003;169:1337-40.
33. Pinkawa M, Fischedick K, Piroth MD, et al. Health-related quality of life after permanent interstitial brachytherapy for prostate cancer. Strahlenther Onkol 2006;182:660-5.
34. 18F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer. J Urol 2002;168:273-80.
35. Qiao L, Yacoub A, McKinstry R, et al. Pharmocologic inhibitors of the mitogen activated protein kinase cascade have the potential to interact with ionizing radiation exposure to induce cell death in carcinoma cells by multiple mechanisms. Cancer Biol Ther 2002;1:168-76.
36. (18)F]-FDG uptake in rat C6 glioma cells. Strahlenther Onkol 2004;180:434-41.
37. Rifkin MD, Zerhouni EA, Gatsonis CA, et al. Comparison of magnetic resonance imaging and ultra-sonography in staging early prostate cancer: results of a multi-institutional cooperative trial. N Engl J Med 1990;323:621-6.
38. Savas A, Warnke PC, Ginap T, et al. The effects of continuous and single-dose radiation on choline uptake in organotypic tissue slice cultures of rabbit hippocampus. Neurol Res 2001;23:669-75.
39. Schoeder H, Larson SM. Positron emission tomography for prostate, bladder, and renal cancer. Semin Nucl Med 2004;34:274-92.
40. Scott SL, Gumerlock PH, Beckett L, et al. Survival and cell cycle kinetics of human prostate cancer cell lines after single- and multifraction exposures to ionizing radiation. Int J Radiat Oncol Biol Phys 2004;59:219-27.
41. Senekowitsch-Schmidtke R, Matzen K, Truckenbrodt R, et al. Tumor cell spheroids as a model for evaluation of metabolic changes after irradiation. J Nucl Med 1998;39:1762-8.
42. Simon EL, Goel HL, Teider N, et al. High dose fractionated ionizing radiation inhibits prostate cancer cell adhesion and beta(1) integrin expression. Prostate 2005;64:83-91.
43. Van Rossum GD, Boyd CA. Sodium-dependent and -independent choline uptake by type II epithelial cells from rat lung. J Membr Biol 1998;162:147-56.
44. Weber WA, Wieder H. Monitoring chemotherapy and radiotherapy of solid tumors. Eur J Nucl Med Mol Imaging 2006;33:Suppl 13:27-37.